Insider trading · Q3 2026 · CIK 2012593

Rapport Therapeutics, Inc. (RAPP) insider trading.

Name: Rapport Therapeutics, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Rapport Therapeutics, Inc. reported 25 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 25 sales worth $7.5M.

Transactions: 25
Purchases (P): 0
Sales (S): 25
Net shares, P minus S: -160,044
Insiders: 3
Last filed: 2026-09-24

Insiders

Insider	Relationship	Transactions	Sales
Ceesay Abraham	Director, Officer · Chief Executive Officer	17	17
Yeleswaram Krishnaswamy	Officer · Chief Development Officer	4	4
Gault Cheryl	Officer · Chief Operating Officer	4	4

Transactions

25 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-23	Ceesay Abraham	S (D)	43	$41.05	456,767	Form 4
2026-09-23	Ceesay Abraham	S (D)	1,952	$39.05	457,025	Form 4
2026-09-23	Ceesay Abraham	S (D)	215	$39.86	456,810	Form 4
2026-09-08	Ceesay Abraham	S (D)	7,141	$45.56	460,046	Form 4
2026-09-08	Ceesay Abraham	S (D)	1,069	$46.01	458,977	Form 4
2026-08-25	Yeleswaram Krishnaswamy	S (D)	16,201	$51.06	195,862	Form 4
2026-08-25	Yeleswaram Krishnaswamy	S (D)	20,799	$50.31	212,063	Form 4
2026-08-25	Ceesay Abraham	S (D)	18,921	$49.57	467,187	Form 4
2026-08-24	Yeleswaram Krishnaswamy	S (D)	13,160	$50	232,862	Form 4
2026-08-19	Yeleswaram Krishnaswamy	S (D)	404	$49.9	246,022	Form 4
2026-08-11	Ceesay Abraham	S (D)	3,664	$46.9	511,402	Form 4
2026-08-11	Ceesay Abraham	S (D)	19,500	$48.04	491,902	Form 4
2026-08-11	Ceesay Abraham	S (D)	5,794	$48.62	486,108	Form 4
2026-08-10	Ceesay Abraham	S (D)	14,171	$45.97	523,436	Form 4
2026-08-10	Ceesay Abraham	S (D)	8,370	$46.75	515,066	Form 4
2026-07-27	Ceesay Abraham	S (D)	2,203	$42.11	537,614	Form 4
2026-07-27	Ceesay Abraham	S (D)	7	$42.74	537,607	Form 4
2026-07-14	Ceesay Abraham	S (D)	2,729	$40.57	539,817	Form 4
2026-07-14	Ceesay Abraham	S (D)	5,481	$39.72	542,546	Form 4
2026-06-30	Gault Cheryl	S (D)	1,000	$43.15	149,914	Form 4
2026-06-30	Gault Cheryl	S (D)	3,308	$42.17	150,914	Form 4
2026-06-30	Gault Cheryl	S (D)	1,900	$40.09	158,014	Form 4
2026-06-30	Gault Cheryl	S (D)	3,792	$41.39	154,222	Form 4
2026-06-29	Ceesay Abraham	S (D)	876	$40.34	548,027	Form 4
2026-06-29	Ceesay Abraham	S (D)	7,344	$39.77	548,903	Form 4

Transaction codes in this quarter

S: 25

Get RAPP insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=2012593&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · RAPP company page · Rapport Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Rapport Therapeutics, Inc. (RAPP)?

In Q3 2026, insiders at Rapport Therapeutics, Inc. reported 25 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 25 sales worth $7.5M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Rapport Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/rapp.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.